The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Animal-derived Immune Globulin Market Research Report 2025
Synopsis
The global Animal-derived Immune Globulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 228%.
This report aims to provide a comprehensive presentation of the global market for Animal-derived Immune Globulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal-derived Immune Globulin.
Report Scope
The Animal-derived Immune Globulin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal-derived Immune Globulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal-derived Immune Globulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Rare Disease Therapeutics
Merck
Sanofi
Wyeth Pharmaceuticals
Protherics
Genzyme
Segment by Type
Liquid
Powder
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal-derived Immune Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal-derived Immune Globulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Animal-derived Immune Globulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 228%.
This report aims to provide a comprehensive presentation of the global market for Animal-derived Immune Globulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal-derived Immune Globulin.
Report Scope
The Animal-derived Immune Globulin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal-derived Immune Globulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal-derived Immune Globulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Rare Disease Therapeutics
Merck
Sanofi
Wyeth Pharmaceuticals
Protherics
Genzyme
Segment by Type
Liquid
Powder
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal-derived Immune Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal-derived Immune Globulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Animal-derived Immune Globulin Market Overview
1.1 Product Overview and Scope of Animal-derived Immune Globulin
1.2 Animal-derived Immune Globulin Segment by Type
1.2.1 Global Animal-derived Immune Globulin Market Value Comparison by Type (2024-2030)
1.2.2 Liquid
1.2.3 Powder
1.3 Animal-derived Immune Globulin Segment by Application
1.3.1 Global Animal-derived Immune Globulin Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Animal-derived Immune Globulin Market Size Estimates and Forecasts
1.4.1 Global Animal-derived Immune Globulin Revenue 2019-2030
1.4.2 Global Animal-derived Immune Globulin Sales 2019-2030
1.4.3 Global Animal-derived Immune Globulin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Animal-derived Immune Globulin Market Competition by Manufacturers
2.1 Global Animal-derived Immune Globulin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Animal-derived Immune Globulin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Animal-derived Immune Globulin Average Price by Manufacturers (2019-2024)
2.4 Global Animal-derived Immune Globulin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Animal-derived Immune Globulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal-derived Immune Globulin, Product Type & Application
2.7 Animal-derived Immune Globulin Market Competitive Situation and Trends
2.7.1 Animal-derived Immune Globulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Animal-derived Immune Globulin Players Market Share by Revenue
2.7.3 Global Animal-derived Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal-derived Immune Globulin Retrospective Market Scenario by Region
3.1 Global Animal-derived Immune Globulin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Animal-derived Immune Globulin Global Animal-derived Immune Globulin Sales by Region: 2019-2030
3.2.1 Global Animal-derived Immune Globulin Sales by Region: 2019-2024
3.2.2 Global Animal-derived Immune Globulin Sales by Region: 2025-2030
3.3 Global Animal-derived Immune Globulin Global Animal-derived Immune Globulin Revenue by Region: 2019-2030
3.3.1 Global Animal-derived Immune Globulin Revenue by Region: 2019-2024
3.3.2 Global Animal-derived Immune Globulin Revenue by Region: 2025-2030
3.4 North America Animal-derived Immune Globulin Market Facts & Figures by Country
3.4.1 North America Animal-derived Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Animal-derived Immune Globulin Sales by Country (2019-2030)
3.4.3 North America Animal-derived Immune Globulin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Animal-derived Immune Globulin Market Facts & Figures by Country
3.5.1 Europe Animal-derived Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Animal-derived Immune Globulin Sales by Country (2019-2030)
3.5.3 Europe Animal-derived Immune Globulin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal-derived Immune Globulin Market Facts & Figures by Country
3.6.1 Asia Pacific Animal-derived Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Animal-derived Immune Globulin Sales by Country (2019-2030)
3.6.3 Asia Pacific Animal-derived Immune Globulin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Animal-derived Immune Globulin Market Facts & Figures by Country
3.7.1 Latin America Animal-derived Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Animal-derived Immune Globulin Sales by Country (2019-2030)
3.7.3 Latin America Animal-derived Immune Globulin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal-derived Immune Globulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal-derived Immune Globulin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Animal-derived Immune Globulin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Animal-derived Immune Globulin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Animal-derived Immune Globulin Sales by Type (2019-2030)
4.1.1 Global Animal-derived Immune Globulin Sales by Type (2019-2024)
4.1.2 Global Animal-derived Immune Globulin Sales by Type (2025-2030)
4.1.3 Global Animal-derived Immune Globulin Sales Market Share by Type (2019-2030)
4.2 Global Animal-derived Immune Globulin Revenue by Type (2019-2030)
4.2.1 Global Animal-derived Immune Globulin Revenue by Type (2019-2024)
4.2.2 Global Animal-derived Immune Globulin Revenue by Type (2025-2030)
4.2.3 Global Animal-derived Immune Globulin Revenue Market Share by Type (2019-2030)
4.3 Global Animal-derived Immune Globulin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Animal-derived Immune Globulin Sales by Application (2019-2030)
5.1.1 Global Animal-derived Immune Globulin Sales by Application (2019-2024)
5.1.2 Global Animal-derived Immune Globulin Sales by Application (2025-2030)
5.1.3 Global Animal-derived Immune Globulin Sales Market Share by Application (2019-2030)
5.2 Global Animal-derived Immune Globulin Revenue by Application (2019-2030)
5.2.1 Global Animal-derived Immune Globulin Revenue by Application (2019-2024)
5.2.2 Global Animal-derived Immune Globulin Revenue by Application (2025-2030)
5.2.3 Global Animal-derived Immune Globulin Revenue Market Share by Application (2019-2030)
5.3 Global Animal-derived Immune Globulin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Animal-derived Immune Globulin Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Rare Disease Therapeutics
6.2.1 Rare Disease Therapeutics Corporation Information
6.2.2 Rare Disease Therapeutics Description and Business Overview
6.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolio
6.2.5 Rare Disease Therapeutics Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Animal-derived Immune Globulin Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Animal-derived Immune Globulin Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Wyeth Pharmaceuticals
6.5.1 Wyeth Pharmaceuticals Corporation Information
6.5.2 Wyeth Pharmaceuticals Description and Business Overview
6.5.3 Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolio
6.5.5 Wyeth Pharmaceuticals Recent Developments/Updates
6.6 Protherics
6.6.1 Protherics Corporation Information
6.6.2 Protherics Description and Business Overview
6.6.3 Protherics Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Protherics Animal-derived Immune Globulin Product Portfolio
6.6.5 Protherics Recent Developments/Updates
6.7 Genzyme
6.6.1 Genzyme Corporation Information
6.6.2 Genzyme Description and Business Overview
6.6.3 Genzyme Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Genzyme Animal-derived Immune Globulin Product Portfolio
6.7.5 Genzyme Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal-derived Immune Globulin Industry Chain Analysis
7.2 Animal-derived Immune Globulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal-derived Immune Globulin Production Mode & Process
7.4 Animal-derived Immune Globulin Sales and Marketing
7.4.1 Animal-derived Immune Globulin Sales Channels
7.4.2 Animal-derived Immune Globulin Distributors
7.5 Animal-derived Immune Globulin Customers
8 Animal-derived Immune Globulin Market Dynamics
8.1 Animal-derived Immune Globulin Industry Trends
8.2 Animal-derived Immune Globulin Market Drivers
8.3 Animal-derived Immune Globulin Market Challenges
8.4 Animal-derived Immune Globulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
